Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.53 |
| ▸ | NSD2 | O96028 | 1/20 | 0.53 |
| ▸ | KMO | O15229 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9356640 | 0.98 | AKR1C3 (0.65) | AKR1C3KMT2AMAPTTDP1MEN1 | |
| SCHEMBL11270798 | 0.96 | AKR1C3 (0.61) | AKR1C3KMT2AMAPTTDP1MEN1 | |
| SCHEMBL11280339 | 0.94 | AKR1C3 (0.59) | AKR1C3KMT2AMAPTTDP1MEN1 | |
| SCHEMBL11196204 | 0.92 | AKR1C3 (0.61) | AKR1C3KMT2AMAPTTDP1MEN1 | |
| Isophthalic Acid SCHEMBL2889737 | 0.91 | PARP10 (0.61) | AKR1C3KMT2AMAPTTDP1MEN1 | |
| SCHEMBL1785471 | 0.90 | KMT2A (0.69) | KMT2AMAPTTDP1MEN1ALDH1A1 | |
| SCHEMBL8405844 | 0.90 | ESR1 (0.56) | AKR1C3KMT2AMAPTTDP1MEN1 | |
| SCHEMBL18965052 | 0.90 | KMO (0.62) | AKR1C3KMT2AMAPTTDP1MEN1 | |
| SCHEMBL28467374 | 0.89 | AKR1C3 (0.62) | AKR1C3KMT2AMAPTTDP1MEN1 | |
| SCHEMBL23064097 | 0.89 | KMT2A (0.62) | AKR1C3KMT2AMAPTTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-06-10 | — | — | US | disclosed |
| CN-106674001-B | A kind of synthetic method of m-methoxybenzoic acid | 三峡大学 | 2019-09-24 | — | — | CN | disclosed |
| CN-100489027-C | Flame-retardant epoxy resin composition and phosphorus-containing compound | CHANGCHUN ARTIFICIAL RESIN FAC (CN) | 2009-05-20 | — | — | CN | disclosed |
| CN-1580120-A | Flame-retardant epoxy resin composition and phosphorus-containing compound | CHANGCHUN ARTIFICIAL RESIN FAC (CN) | 2005-02-16 | — | — | CN | disclosed |
| CN-1580108-A | Phosphorus-containing compound | ARTIFICIAL RESIN FACTORY CO LT (CN) | 2005-02-16 | — | — | CN | disclosed |
| US-5683682-A | Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms | ROBERTET S.A. (FR) | 1997-11-04 | — | — | US | disclosed |
| EP-0606197-B1 | USE OF AROMATIC BENZOATES AS PERSONAL DEODORANTS | ROBERTET SA (FR) | 1996-01-31 | — | — | EP | disclosed |
| EP-0606197-A1 | DERIVATIVES OF AROMATIC BENZOATES AS INHIBITORS OF ESTERASE-PRODUCING MICRO-ORGANISMS. | ROBERTET SA (FR) | 1994-07-20 | — | — | EP | disclosed |
| WO-1991007165-A1 | DERIVATIVES OF AROMATIC BENZOATES AS INHIBITORS OF ESTERASE-PRODUCING MICRO-ORGANISMS | ROBERTET S.A. (FR) | 1991-05-30 | — | — | WO | disclosed |
| US-4006239-A | Benzoic acid amides for mycobacterium infections | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | AKR1C3 1611/4885KMT2A 4555/4885MAPT 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.